info@myokarditida.cz

Myokarditida

Webový průvodce o nemoci myokarditida, její diagnostice a léčbě.
  • EXPERTS
  • WEB
    • About the web
    • Warning
  • MYOCARDITIS
    • Definition of myocarditis and inflammatory cardiomyopathy (ICMP)
    • Epidemiology
    • Aetiology
    • Pathogenesis
    • Histopathology
  • CLASSIFICATION
    • Classification of myocarditis and ICMP
    • Fulminant, acute and chronic myocarditis
    • Eosinophilic myocarditis
    • Giant-cell myocarditis
    • Cardiac sarcoidosis
    • Myocarditis in HIV positive patients
    • Myocarditis connected with autoimmune diseases
    • Chagas disease
  • DIAGNOSIS
    • Diagnosis generally
    • Subjective symptoms and physical examination
    • ECG and Holter monitoring
    • ECHO and Chest X-Ray
    • Cardiac magnetic resonance imaging (CMRI)
    • Laboratory examination
    • Endomyocardial biopsy (EMB) and nuclear methods and cardiac catheterization
  • TREATMENT
    • Treatment generally
    • Regime measures
    • Heart failure therapy
    • Treatmenf of arrhythmias and thromboembolism
    • Treatment with ATB and antivirotics
    • Immunologial therapy
      • Immunological therapy generally
      • Immunoglobulines
      • Immunoadsorption and interferons
      • Immunosuppressive therapy
    • Mechanical support of inner organs and heart transplant
    • Prognosis
  • OTHER
    • Retrospective study
      • Aims
      • Methods
      • Results
      • Discussion
    • References
    • Abbreviations
    • Contact
Home
/
Profesionální verze
/
Klasifikace

Chagas disease

14.3.2017 Jan Habásko

Chagas disease is a parasitic disease caused by an infection with Trypanosoma cruzi. It is mostly found in the area of Central and South America [26]. According to WHO, 8 million people are infected worldwide, whereas 10 000 infected patients die yea…

Více ...

Myocarditis connected with autoimmune diseases

14.3.2017 Jan Habásko

Myocarditis is connected with a considerable amount of autoimmune diseases (see chapter Aetiology). Some of them are already mentioned in the chapter Více ...

Myocarditis in HIV positive patients

14.3.2017 Jan Habásko

Cardiac impairment in HIV positive patients is a very frequent complication which is observed in 25 to 75 % of patients. In patients with AIDS, myocarditis was post-mortem identified in 40 to 52 % of cases [34]. Some resources warn about the increase…

Více ...

Cardiac sarcoidosis

14.3.2017 Jan Habásko

Sarcoidosis is a multiorgan granulomatous inflammatory disease whose prevalence in the Czech Republic is approximately 60 cases per 100 000 inhabitants [50]. It affects most frequently lungs and lymphatic nodes. Cardiac sarcoidosis manifests in about…

Více ...

Giant-cell myocarditis

14.3.2017 Jan Habásko

Giant-cell myocarditis (GCM) is a rare form of myocarditis mostly with a dramatic course and life-threatening complications.

GCM is characterized by the histopathological finding of giant multinuclear cells, infiltration with eosinophils and T lym…

Více ...

Eosinophilic myocarditis

14.3.2017 Jan Habásko

Eosinophilic myocarditis is a rare type of myocarditis usually caused by a hypersensitive or allergic reaction. Its prevalence in myocardial autopsy examinations was approximately 0,5 % [25]. It is more frequent in patients who are undergoing heart t…

Více ...

Fulminant, acute and chronic myocarditis

14.3.2017 Jan Habásko

Fulminant myocarditis

It is an uncommon form of myocarditis which is characterized by a fast progression of the disease. Usually in the term of just several days, often one or two, before the first manifestation of the disease, prodrome of …

Více ...

Classification of myocarditis and ICMP

14.3.2017 Jan Habásko

Classification of myocarditis and ICMP is not stabilized so far and develops with increasing knowledge about aetiology and pathogenesis of the disease. There are several classifications which may be combined.

It may be classified based on the aeti…

Více ...

Navigace/Navigation

  • HOME
  • ABOUT
    • About project
    • Warning
    • Stories
      • My story
  • MYOCARDITIS
    • Definition of myocarditis
    • Causes (Etiology)
    • What´s going on in the body (pathogenesis)
    • Symptoms
    • Types of myocarditis
    • Dictionary
  • DIAGNOSIS & TREATMENT
    • Diagnosis
      • Physical examination
      • Electrocardiogram (ECG)
      • X-Ray
      • Echocardiography (ECHO)
      • Cardiac magnetic resonance imaging (CMRI)
      • Lab testing
      • Endomyocardial biopsy (EMB)
      • Scintigraphy and cardiac catheterization
    • Treatment possibilities
      • Treatment possibilities
      • Heart failure treatment
      • Treatment with antivirotics and antibiotics
      • Immunological treatment
      • Other treatment possibilities
    • Life with myocarditis
  • RESEARCH
    • COVID-19
      • COVID-19 (1.část) – úvod
      • COVID-19 (2.část) – příznaky, diagnostika a léčba
      • COVID-19 (3.část) – imunitní systém
      • COVID-19 (4.část) – vakcíny proti SARS-CoV-2
      • COVID-19 (5.část) – imunitní odpověď po nákaze a očkování
      • COVID-19 (6.část) – myokarditida
      • COVID-19 (7.část) – dopady na srdce a cévy
      • COVID-19 (8.část) – dopady infekce
      • COVID-19 novinky 2023 – 1. část
      • COVID-19 novinky 2023 – 2. část
      • COVID-19 – zdroje
    • News
      • Telbivudin
      • Interleukin 1beta inhibitors
      • Rituximab
      • British Heart Foundation
      • Treatment with interferon beta
      • Immunosuppressive therapy of myocarditis
    • What do the Doctors Say?
      • Dr. Renzo Marcolongo
      • Dr. Andrea Silvio Giordani
      • Professor Leslie T. Cooper, Jr.
      • Theodor Adla M.D.
      • Veronika Stará M.D.
      • Lenka Roblová M.D.
  • CONTACT

Kontakty/Contacts

info@myokarditida.cz

Sdílení/Share

  • Facebook
  • Twitter
  • Google+
  • Pinterest
  • LinkedIn
  • Tumblr
  • StumbleUpon
  • Reddit

Sociální sítě/Social networks

Záštita/Patronage

Zpětné odkazy/Links

CZIN.eu TOPlist TOPlist Přidat.eu
Myokarditida © 2026   |